Skip to main content
. 2017 May 11;8(26):43114–43129. doi: 10.18632/oncotarget.17810

Table 1. Time course of differential protein accumulation by LB373 melanoma cells after treatment with cisplatin.

Identification Spot Relative Spot Intensity (h)
8 16 24
60 kDa Heat Shock Protein (Hsp60) 48 1.2 1.3 3.3
50 3.2 3.5 n.d.
52 3.1 2.6 1.8
53 1.7 1.2 6.8
67 0.1 0.5 0.1
78 kDa glucose-regulated precursor (GRP78) 39 2.0 1.4 4.6
156 0.4 1.4 4.0
317 2.0 2.4 5.8
361 0.6 0.9 2.0
Actin, cytoplasmic 1 (Beta-actin) 146 3.5 6.0 4.1
147 2.9 4.3 3.0
150 3.6 3.7 6.8
152 3.7 3.3 5.0
Alpha enolase 211 1.9 2.0 1.5
ATP Synthase beta chain, mitochondrial precursor 90 2.0 2.9 1.3
98 0.6 0.7 12.0
ATP Synthase D Chain, mitochondrial 441 0.9 1.3 1.8
Calreticulin Precursor 120 0.9 1.4 0.3
479 0.4 0.4 0.8
Cathepsin D precursor 328 0.7 2.2 1.9
329 0.5 1.1 1.9
Endoplasmic reticulum protein ERp29 precursor 359 2.5 2.8 2.7
Endoplasmin precursor 45 n.d. n.d. 8.2
Eukaryotic translation initiation facotr 3 subunit 2 214 1.1 2.0 2.0
220 0.7 0.5 1.1
F-actin capping protein alpha-1 subunit 250 1.2 2.7 2.3
Galectin-1 514 0.8 1.0 1.9
517 0.7 1.3 2.4
Glutathione S-transferase P 412 1.7 1.9 2.4
Heat-Shock protein beta-1 370 2.7 2.4 0.5
375 2.2 4.6 3.3
Heat shock 70 kDa protein 1 (HSP70.1) 183 1.8 2.8 1.7
Inorganic pyrophosphatase 279 2.7 2.9 n.d.
Lamin A/C 376 0.9 3.9 4.4
Myosin light chain alkali, non-muscle isoform 500 1.4 2.4 2.9
Nucleophosmin 221 0.3 4.1 n.d
222 1.5 3.2 n.d
474 1.8 1.4 1.3
Nucleoside diphosphate kinase A 498 0.4 0.3 0.7
Peroxiredoxin 4 371 0.5 1.2 2.0
Peroxiredoxin 6 383 2.0 1.1 1.4
Phosphoglycerate kinase 1 396 0.8 0.5 1.1
Prohibitin 339 1.4 1.6 2.0
Protein disulfide isomerase A3 precursor 22 2.6 3.1 1.1
55 3.4 3.0 4.5
57 3.5 3.7 2.6
347 1.1 1.1 2.8
Rho GDP-dissociation inhibitor 1 384 0.9 1.6 2.3
Stress-70 protein, mitochondrial precursor 36 2.5 2.1 1.3
37 1.7 2.3 3.0
T-complex protein 1, epsilon subunit 47 4.4 3.9 5.1
Triosephosphate isomerase 388 2.3 2.2 2.5
394 2.5 1.6 1.7
Tropomyosin alpha 3 chain 310 5.4 3.6 3.4
312 4.6 3.7 1.7
Tubulin beta-5 chain 286 0.5 0.3 0.3
292 0.9 1.0 0.4
Ubiquinol-cytochrome C reductase complex core protein 1 116 1.6 2.5 3.2
Vimentin 80 2.8 0.8 n.d.
93 1.7 1.0 n.d.
154 0.9 1.1 4.1
398 0.7 0.8 2.8

Data are reported as the relative intensity of IEF-SDS-PAGE, CBB-250 stained gel spots after 8, 16 and 24h incubation with 25μM cisplatin, compared with untreated cells. Data for each time point are the average obtained for 3 gels. The Table lists 34 regulated proteins identified by MALDI-TOF which were detected as 62 isoelectric forms. n.d (not detected)

HHS Vulnerability Disclosure